I agree that this site is using cookies. You can find further informations here.
X
Jasielec, J.K.
20  results:
Search for persons X
?
1

Carfilzomib (CFZ, Kyprolis®), lenalidomide (LEN, Revlimid®)..:

Jakubowiak, A.J. ; Griffith, K. ; Jasielec, J.K....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e42 , 2015
Link: https://doi.org/10.1016/..
 
?
2

Measurable residual disease assessed by mass spectrometry i..:

Derman, Benjamin A. ; Stefka, Andrew T. ; Jiang, Ken...
Blood Cancer Journal.  11 (2021)  2 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
3

Clinician attitudes and practices toward measurable residua..:

Derman, Benjamin A. ; Jasielec, Jagoda K. ; Jakubowiak, Andrzej J.
British Journal of Haematology.  190 (2020)  3 - p. 470-472 , 2020
Link: https://doi.org/10.1111/..
 
?
4

Phase 1 study of selinexor plus carfilzomib and dexamethaso..:

Jakubowiak, Andrzej J. ; Jasielec, Jagoda K. ; Rosenbaum, Cara A....
British Journal of Haematology.  186 (2019)  4 - p. 549-560 , 2019
Link: https://doi.org/10.1111/..
 
?
5

Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®)..:

Zimmerman, Todd M. ; Griffith, Kent ; Jasielec, Jagoda K....
Biology of Blood and Marrow Transplantation.  22 (2016)  3 - p. S40 , 2016
Link: https://doi.org/10.1016/..
 
?
6

Measurable residual disease assessed by mass spectrometry i..:

Derman, Benjamin A ; Stefka, Andrew T ; Jiang, Ken...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873068/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Carfilzomib, lenalidomide, and dexamethasone plus transplan..:

Jasielec, Jagoda K ; Kubicki, Tadeusz ; Raje, Noopur...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714092/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
8

Phase 1 study of selinexor plus carfilzomib and dexamethaso..:

Jakubowiak, Andrzej J ; Jasielec, Jagoda K ; Rosenbaum, Cara A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772147/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
9

Modeling of Electrodiffusion Processes from Nano to Macro S..:

Szyszkiewicz, K. ; Jasielec, J. J. ; Danielewski, M...
Journal of The Electrochemical Society.  164 (2017)  11 - p. E3559-E3568 , 2017
Link: https://doi.org/10.1149/..
 
?
10

Continuous Modeling of Calcium Transport Through Biological..:

Jasielec, J. J. ; Filipek, R. ; Szyszkiewicz, K...
Journal of Materials Engineering and Performance.  25 (2016)  8 - p. 3285-3290 , 2016
Link: https://doi.org/10.1007/..
 
?
11

Current approaches to the initial treatment of symptomatic ..:

Jasielec, Jagoda K ; Jakubowiak, Andrzej J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839860.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
12

Computer simulations of electrodiffusion problems based on ..:

Jasielec, J.J. ; Filipek, R. ; Szyszkiewicz, K....
Computational Materials Science.  63 (2012)  - p. 75-90 , 2012
Link: https://doi.org/10.1016/..
 
?
13

Measurable residual disease assessed by mass spectrometry i..:

Benjamin A. Derman ; Andrew T. Stefka ; Ken Jiang...
https://doi.org/10.1038/s41408-021-00418-2.  , 2021
Link: https://doi.org/10.1038/..
 
?
14

Diagnostic Value of Subjective Memory Complaints Assessed w..:

Laske, Christoph ; Sohrabi, Hamid R. ; Jasielec, Mateusz S....
BioMed Research International.  2015 (2015)  - p. 1-7 , 2015
Link: https://doi.org/10.1155/..
 
?
15

Utility of perfusion PET measures to assess neuronal injury..:

Joseph-Mathurin, N ; Su, Y ; Blazey, TM...
https://discovery.ucl.ac.uk/id/eprint/10061480/1/Joseph-Mathurin_1-s2.0-S2352872918300642-main.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
1-15